HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

MET

MetLife, Inc. (S&P 500)

Financial Services — Insurance - Life

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it offers fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity and funded reinsurance solutions; credit insurance products; accident & health products covering hospitalization, cancer, critical illness, income protection, and scheduled medical reimbursement plans; and protection against long-term health care services. The company was incorporated in 1999 and is based in New York, New York.

Buy 1.9 / 5 16 analysts
$97.49
+$2.30 (+2.42%)
Target: $97.75 (0.3%)
Sign in to add MET to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$62.73B
P/E Ratio (TTM)18.86
Forward P/E8.87
EPS (TTM)$5.17
Dividend Yield2.49%
Profit Margin4.67%
Revenue Growth2.70%
ROE13.01%
Debt/Equity178.02
Recommendation Buy 1.9
Analyst Target$97.75
Analysts16
Indexes S&P 500

Technical Indicators

RSI (14)79.0
Beta0.78
SMA 20$92.10
SMA 40$88.78
52-Week High$97.69
52-Week Low$67.33
50-Day Avg$87.15
200-Day Avg$79.41
Avg Volume$3.63M
Volume$3.99M

Performance Analysis

NEUTRAL

MET presents a mixed picture with both positive and negative indicators.

- Trading near its 52-week high ($97.69), which may indicate limited upside.
- RSI at 79.0 indicates overbought conditions — a pullback may be due.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
~ Modest revenue growth of 2.7% year-over-year.
+ Wall Street consensus is "Buy" from 16 analysts.
+ Average analyst target of $97.75 implies 0.3% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 28, 2026 21:01 UTC

Back to Screener Export Report